The mode of action of alpha 1-adrenoceptor blockers on blood lipids.
Jansen
H
H
Internal Medicine III, Erasmus University, Rotterdam, The Netherlands.
D000818:Animals; D001262:Atenolol / Q000008:administration & dosage / Q000097:blood; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D008076:Cholesterol, HDL / Q000097:blood*; D006224:Cricetinae; D017292:Doxazosin; D006801:Humans; D008071:Lipoprotein Lipase / Q000097:blood; D008647:Mesocricetus; D011224:Prazosin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000097:blood / Q000494:pharmacology*; D011433:Propranolol / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood*
D002791:Cholesterol, Dietary; D008076:Cholesterol, HDL; D014280:Triglycerides; D001262:Atenolol; D011433:Propranolol; D008071:Lipoprotein Lipase; D017292:Doxazosin; D011224:Prazosin